Table 1. Clinicopathological and univariate survival data of 221 patients with gastric cancer.
| All cases n=221 (%) | Survival P-value | All cases n=221 (%) | Survival P-value | ||
|---|---|---|---|---|---|
| Gender | pT status | ||||
| Male | 142 (64) | 0.49 | pT1 | 14 (6) | <0.001 |
| Female | 79 (36) | pT2 | 86 (39) | ||
| pT3 | 110 (50) | ||||
| Age | pT4 | 11 (5) | |||
| Median (range) | 71 (34–96) | ||||
| pN status | |||||
| Age categories (years) | pN0 | 67 (30) | <0.001 | ||
| <50 | 12 (5) | 0.15 | pN1 | 96 (43) | |
| 50–70 | 80 (36) | pN2 | 44 (20) | ||
| ⩾70 | 129 (58) | pN3 | 14 (6) | ||
| Tumour type | pM status | ||||
| Intestinal | 147 (67) | 0.54 | pM0 | 201 (91) | 0.07 |
| Diffuse | 44 (20) | pM1 | 8 (4) | ||
| Mixed | 30 (14) | Missing | 12 (5) | ||
| Tumour location | Clinical stage | ||||
| Cardia | 43 (20) | 0.04 a | I | 45 (20) | <0.001 |
| Body | 53 (24) | II | 52 (24) | ||
| Antrum | 93 (42) | III | 85 (39) | ||
| Whole stomach | 5 (2) | IV | 27 (12) | ||
| Missing | 27 (12) | Missing | 12 (5) | ||
Significant correlations are in bold.
a
The whole stomach shows shorter survival than does the antrum, body, and cardia separately.